Eli Lilly Releasing Cheaper Insulin Generic to Compete With Lispro Products
Eli Lilly (NYSE: LLY) took another big swipe at America's rebate-hungry reimbursement system by launching a generic competitor for two more of its popular insulin lispro containing products.
Diabetes patients that want to manage their blood sugar levels with Humalog Mix 75/25 or Humalog Junior will have a new less expensive option. Eli Lilly will offer generic versions of both insulin-lispro containing brands.
Image source: Getty Images.
Source Fool.com
